1.Bishop, NJ, Morley, R, Day, JP et al. (1997) Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. New Engl J Med 336, 1557–1561.
2.Burn, DJ & Bates, D (1998) Neurology and the kidney. J Neurol Neurosurg Psychiatry 65, 810–821.
3.Cusamo, F & Savazzi, G (1986) Cerebral computed tomography in uremic hemodialyzed patients. J Comput Assist Tomogr 10, 567–570.
4.McDermott, JR, Smith, AI, Ward, MK et al. (1978) Brain-aluminium concentration in dialysis encephalopathy. Lancet 1 (8070), 901–904.
5.Bolla, KI, Briefel, G, Spector, D et al. (1992) Neurocognitive effects of aluminium. Arch Neurol 49, 1021–1026.
6.White, DM, Longstreth, WT, Rosenstock, L et al. (1992) Neurologic syndrome in 25 workers from an aluminium smelting plant. Arch Intern Med 152, 1443–1448.
7.Ott, SM, Maloney, NA, Klein, GL et al. (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Int Med 98, 910–914.
8.Ott, SM, Maloney, NA, Coburn, JW et al. (1982) The prevalence of bone aluminium deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307, 709–713.
9.Goodman, WG, Gilligan, J & Horst, RL (1984) Short-term aluminium administration in the rat: effects on bone formation and relationship to renal osteomalacia. J Clin Invest 73, 171–181.
10.Sedman, AB, Alfrey, AC, Miller, NL et al. (1987) Tissue and cellular basis for impaired bone formation in aluminium-related osteomalacia in the pig. J Clin Invest 79, 86–92.
11.Goodman, WG, Henry, DA, Horst, R et al. (1984) Parenteral aluminium administration in the dog. II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int 25, 370–375.
12.Moreno, A, Dominguez, C & Ballabriga, A (1994) Aluminum in the neonate related to parenteral nutrition. Acta Paediatr 83, 25–29.
13.Mouser, JF, Wu, AH & Herson, VC (1998) Aluminum contamination of neonatal parenteral nutrient solutions and additives. Am J Health Syst Pharm 55, 1071–1072.
14.McGraw, M, Bishop, N, Jameson, R et al. . (1986) Aluminum content of milk formulae and intravenous fluids used in infants. Lancet 1, 157.
15.Sedman, AB, Klein, GL, Merritt, RJ et al. (1985) Evidence of aluminium loading in infants receiving intravenous therapy. New Engl J Med 312, 1337–1343.
16.Bayley, N (1969) Bayley Scales of Infant Development. New York: Psychological Corporation.
17.Wechsler, D (1999) Wechsler Abbreviated Scale of Intelligence Manual. San Antonio, TX: Harcourt Brace & Company.
18.Wechsler, D (1993) Wechsler Objectives Reading Dimensions Test. Sidcup, UK: Psychological Corporation.
19.Wechsler, D (1996) Wechsler Objectives Numerical Dimensions Test. Sidcup, UK: Psychological Corporation.
20.Talley, H (1993) Children's Auditory Verbal Learning Test (CAVLT-2). Odessa, FL: Psychological Assessment Resources.
21.Cohen, M (1997) Children's Memory Scale (CMS). Sidcup, UK: Psychological Corporation.
22.Corsi, PM (1972) Human memory and the medial temporal region of the brain. Unpublished doctoral dissertation, McGill University, Montreal, Canada.
23.Emslie, H, Wilson, C, Burden, V et al. . (2003) Behavioural Assessment of the Dysexecutive Syndrome in Children (BADS-C). Suffolk, UK: Thames Valley Test Company.
24.Fewtrell, MS, Bishop, NJ, Edmonds, CJ et al. . (2009) Aluminum exposure from parenteral nutrition in preterm infants: bone health at 15-year follow-up. Pediatrics 124, 1372–1379.
25.Fewtrell, MS (2006) Osteoporosis; is primary prevention possible? In Primary prevention by Nutrition Intervention in Infancy and Childhood, pp. 135–152 [Lucas, A and Sampson, HA]. Nestle Nutrition Workshop Series Pediatric Program 57. Karger, Switzerland.
26.Cirmanova, V, Beyer, M, Starka, L et al. . (2008) The effect of leptin on bone – an evolving concept of action. J Bone Min Res 57, S143–S151.
27.Elefteriou, F (2008) Regulation of bone remodelling by the central and peripheral nervous system. Arch Biochem Biophys 473, 231–236.
28.Hernandez, CJ (2003) Theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteopos Int 14, 843–847.
29.Food and Drug Administration (2003) Amendment of regulations on parenteral nutrition; delay of effective date. Fed Register 68, 32979–32981.
30.Poole, RL, Hintz, SR, Mackenzie, NI et al. . (2008) Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. J Parenter Enteral Nutr 32, 242–246.
31.Poole, RL, Schiff, L, Hintz, SR et al. . (2010) Aluminum content of parenteral nutrition in neonates: measured versus calculated levels. J Pediatr Gastro Nutr 50, 208–211.
32.MHRA Public Assessment Report (2010) Calcium gluconate injection 10% in 10 ml glass containers: risk of aluminium exposure. http://www.mhra.gov.uk